We therefore proposed transfusing 20% human albumin solution (HAS) to antagonise the effects of PGE26 and prevent infection in our randomized controlled trial (RCT), ATTIRE (Albumin to Prevent Infection in Chronic Liver Failure). This evidence concerns the gene ALB and chronic liver failure.